Actively Recruiting
Timing of Anemia Screening and Iron Treatment Before Conception Versus First Trimester Impact on Iron Deficiency Anemia in Late Pregnancy A Cluster Randomized Trial
Led by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Updated on 2026-09-17
960
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the timing of anemia screening and iron supplementation in women to prevent iron deficiency anemia during late pregnancy. This study compares the effects of screening and treatment before conception versus during the first trimester of pregnancy. The trial aims to understand how early intervention might influence anemia control and maternal and infant health outcomes. Participants in the study are divided into two groups based on township assignment. One group undergoes anemia screening and receives oral iron treatment before conception if needed, including hemoglobin and serum ferritin tests. The other group receives the same screening and treatment during early pregnancy around 12 weeks gestation. Both groups are given oral ferrous succinate with vitamin C and monitored through scheduled blood tests. Throughout the study, women planning to conceive or in early pregnancy will be monitored for hemoglobin and ferritin levels to track anemia status from late pregnancy 28 weeks gestation until delivery. The main outcome measured is the proportion of participants who have iron deficiency anemia during this late pregnancy period. Participants will provide informed consent and complete study procedures during the trial, which runs from 2026 to 2029.
CONDITIONS
Brief Title
Preconception vs First-Trimester Screening and Treatment for Iron Deficiency Anemia
Research Team
P
Peipei Hu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here